Damora Therapeutics, Inc. (DMRA)

The biotech granted non-qualified options at $26.01 a share, with 25% vesting after one year and the rest monthly over 36 months.

DRAM stock price has slumped by 25% from its highest level on record, as some of its biggest risks start to unfold.

The firm’s fifty day moving average price is $23.72 and its 200-day moving average price is $25.47. The company has a market cap of $1.68 billion, a price-to-earnings ratio of -4.90 and a beta of 1.46. Damora Therapeutics, Inc. Common Stock (NASDAQ:DMRA – Get Free Report) last posted its ...

Dominion Energy stock is back in focus after a roughly 47.6% return over the past three years, with the market now weighing that strong performance against a valuation picture that screens as mixed rather than clearly cheap or clearly expensive. Over the last three years, Dominion Energy has ...

See the latest Damora Therapeutics Inc Ordinary Shares stock price (DMRA:XNAS), related news, valuation, dividends and more to help you make your investing decisions.